These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 25011056)

  • 1. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
    Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of β-arrestin1 and β-arrestin2 on somatostatin receptors in murine AtT-20 corticotroph tumor cells.
    Kageyama K; Hagiwara R; Niioka K; Takayasu S; Daimon M
    Endocr J; 2021 Feb; 68(2):163-170. PubMed ID: 32963176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.
    Batista DL; Zhang X; Gejman R; Ansell PJ; Zhou Y; Johnson SA; Swearingen B; Hedley-Whyte ET; Stratakis CA; Klibanski A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4482-8. PubMed ID: 16940446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
    Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
    Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
    Castillo V; Theodoropoulou M; Stalla J; Gallelli MF; Cabrera-Blatter MF; Haedo MR; Labeur M; Schmid HA; Stalla GK; Arzt E
    Neuroendocrinology; 2011; 94(2):124-36. PubMed ID: 21525729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
    Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
    Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
    Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
    Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
    van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatostatin analogs in Cushing's disease.
    van der Hoek J; Lamberts SW; Hofland LJ
    Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
    Hagiwara R; Kageyama K; Niioka K; Takayasu S; Tasso M; Daimon M
    Peptides; 2021 Feb; 136():170441. PubMed ID: 33181265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.
    van der Hoek J; Waaijers M; van Koetsveld PM; Sprij-Mooij D; Feelders RA; Schmid HA; Schoeffter P; Hoyer D; Cervia D; Taylor JE; Culler MD; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E278-87. PubMed ID: 15769796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphidicolin inhibits cell proliferation via the p53-GADD45β pathway in AtT-20 cells.
    Kageyama K; Sugiyama A; Murasawa S; Asari Y; Niioka K; Oki Y; Daimon M
    Endocr J; 2015; 62(7):645-54. PubMed ID: 25948499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
    Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
    Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide and the novel multireceptor ligand somatostatin receptor agonist pasireotide (SOM230) block the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary.
    Nolan LA; Schmid HA; Levy A
    Endocrinology; 2007 Jun; 148(6):2821-7. PubMed ID: 17347306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
    Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
    Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.